Pediatric sinonasal malignancies: A population-based analysis

Sei Y. Chung, Aykut A Unsal, Suat Kılıç, Soly Baredes, James K. Liu, Jean Anderson Eloy

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Introduction Pediatric Sinonasal Malignancies (PedsSNM) are rare and usually associated with a poor prognosis. We aim to investigate the epidemiology, tumor characteristics, and survival of PedsSNM using a population-based database to augment the scant literature on this topic. Methods The Surveillance, Epidemiology, and End Results database was queried for patients ≤18 years diagnosed with PedsSNM between the years of 1973 and 2013. Data on incidence, tumor characteristics, and survival were analyzed. Results In total, 210 patients with PedsSNM were identified. Demographically, 54.3% were female, 72.6% were white, and the mean age was 10.7 years. Overall incidence was 0.036 per 100,000 individuals between the years of 2000 and 2013. The nasal cavity was the most frequent primary site (37.1%) and rhabdomyosarcoma was the most frequent malignancy (50.5%). Five-, 10-, and 20-year disease-specific survival (DSS) rates were 60.2%, 46.1%, and 20.6%, respectively. Grade IV tumors made up the largest group (37.3%), and such tumors exhibited the worst 5-, 10-, and 20-year survival (P < 0.05). Distant disease predicted the worst 5-, 10-, and 20-year survival, followed by regional, then localized disease (P < 0.01). Patients treated with surgery alone had a higher 20-year survival (P = 0.0425). No significant differences in survival were observed between race, gender, primary site, or histology. Conclusions PedsSNM frequently presented as Grade IV tumors. The nasal cavity was the most common primary site and rhabdomyosarcoma was the most frequent histology. Patients receiving surgery alone had the highest survival; however, this may be a reflection of smaller, less aggressive tumors preferentially being treated with surgery alone.

Original languageEnglish (US)
Pages (from-to)97-102
Number of pages6
JournalInternational Journal of Pediatric Otorhinolaryngology
Volume98
DOIs
StatePublished - Jul 1 2017
Externally publishedYes

Fingerprint

Pediatrics
Survival
Population
Neoplasms
Rhabdomyosarcoma
Nasal Cavity
Histology
Epidemiology
Databases
Incidence
Survival Rate

Keywords

  • Pediatric carcinoma
  • Pediatric malignancies
  • Rhabdomyosarcoma
  • Sinonasal carcinoma
  • Sinonasal malignancies
  • Survival

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Otorhinolaryngology

Cite this

Pediatric sinonasal malignancies : A population-based analysis. / Chung, Sei Y.; Unsal, Aykut A; Kılıç, Suat; Baredes, Soly; Liu, James K.; Eloy, Jean Anderson.

In: International Journal of Pediatric Otorhinolaryngology, Vol. 98, 01.07.2017, p. 97-102.

Research output: Contribution to journalArticle

Chung, Sei Y. ; Unsal, Aykut A ; Kılıç, Suat ; Baredes, Soly ; Liu, James K. ; Eloy, Jean Anderson. / Pediatric sinonasal malignancies : A population-based analysis. In: International Journal of Pediatric Otorhinolaryngology. 2017 ; Vol. 98. pp. 97-102.
@article{90d5db4bec30491e8da838511bd06326,
title = "Pediatric sinonasal malignancies: A population-based analysis",
abstract = "Introduction Pediatric Sinonasal Malignancies (PedsSNM) are rare and usually associated with a poor prognosis. We aim to investigate the epidemiology, tumor characteristics, and survival of PedsSNM using a population-based database to augment the scant literature on this topic. Methods The Surveillance, Epidemiology, and End Results database was queried for patients ≤18 years diagnosed with PedsSNM between the years of 1973 and 2013. Data on incidence, tumor characteristics, and survival were analyzed. Results In total, 210 patients with PedsSNM were identified. Demographically, 54.3{\%} were female, 72.6{\%} were white, and the mean age was 10.7 years. Overall incidence was 0.036 per 100,000 individuals between the years of 2000 and 2013. The nasal cavity was the most frequent primary site (37.1{\%}) and rhabdomyosarcoma was the most frequent malignancy (50.5{\%}). Five-, 10-, and 20-year disease-specific survival (DSS) rates were 60.2{\%}, 46.1{\%}, and 20.6{\%}, respectively. Grade IV tumors made up the largest group (37.3{\%}), and such tumors exhibited the worst 5-, 10-, and 20-year survival (P < 0.05). Distant disease predicted the worst 5-, 10-, and 20-year survival, followed by regional, then localized disease (P < 0.01). Patients treated with surgery alone had a higher 20-year survival (P = 0.0425). No significant differences in survival were observed between race, gender, primary site, or histology. Conclusions PedsSNM frequently presented as Grade IV tumors. The nasal cavity was the most common primary site and rhabdomyosarcoma was the most frequent histology. Patients receiving surgery alone had the highest survival; however, this may be a reflection of smaller, less aggressive tumors preferentially being treated with surgery alone.",
keywords = "Pediatric carcinoma, Pediatric malignancies, Rhabdomyosarcoma, Sinonasal carcinoma, Sinonasal malignancies, Survival",
author = "Chung, {Sei Y.} and Unsal, {Aykut A} and Suat Kılı{\cc} and Soly Baredes and Liu, {James K.} and Eloy, {Jean Anderson}",
year = "2017",
month = "7",
day = "1",
doi = "10.1016/j.ijporl.2017.04.032",
language = "English (US)",
volume = "98",
pages = "97--102",
journal = "International Journal of Pediatric Otorhinolaryngology",
issn = "0165-5876",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Pediatric sinonasal malignancies

T2 - A population-based analysis

AU - Chung, Sei Y.

AU - Unsal, Aykut A

AU - Kılıç, Suat

AU - Baredes, Soly

AU - Liu, James K.

AU - Eloy, Jean Anderson

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Introduction Pediatric Sinonasal Malignancies (PedsSNM) are rare and usually associated with a poor prognosis. We aim to investigate the epidemiology, tumor characteristics, and survival of PedsSNM using a population-based database to augment the scant literature on this topic. Methods The Surveillance, Epidemiology, and End Results database was queried for patients ≤18 years diagnosed with PedsSNM between the years of 1973 and 2013. Data on incidence, tumor characteristics, and survival were analyzed. Results In total, 210 patients with PedsSNM were identified. Demographically, 54.3% were female, 72.6% were white, and the mean age was 10.7 years. Overall incidence was 0.036 per 100,000 individuals between the years of 2000 and 2013. The nasal cavity was the most frequent primary site (37.1%) and rhabdomyosarcoma was the most frequent malignancy (50.5%). Five-, 10-, and 20-year disease-specific survival (DSS) rates were 60.2%, 46.1%, and 20.6%, respectively. Grade IV tumors made up the largest group (37.3%), and such tumors exhibited the worst 5-, 10-, and 20-year survival (P < 0.05). Distant disease predicted the worst 5-, 10-, and 20-year survival, followed by regional, then localized disease (P < 0.01). Patients treated with surgery alone had a higher 20-year survival (P = 0.0425). No significant differences in survival were observed between race, gender, primary site, or histology. Conclusions PedsSNM frequently presented as Grade IV tumors. The nasal cavity was the most common primary site and rhabdomyosarcoma was the most frequent histology. Patients receiving surgery alone had the highest survival; however, this may be a reflection of smaller, less aggressive tumors preferentially being treated with surgery alone.

AB - Introduction Pediatric Sinonasal Malignancies (PedsSNM) are rare and usually associated with a poor prognosis. We aim to investigate the epidemiology, tumor characteristics, and survival of PedsSNM using a population-based database to augment the scant literature on this topic. Methods The Surveillance, Epidemiology, and End Results database was queried for patients ≤18 years diagnosed with PedsSNM between the years of 1973 and 2013. Data on incidence, tumor characteristics, and survival were analyzed. Results In total, 210 patients with PedsSNM were identified. Demographically, 54.3% were female, 72.6% were white, and the mean age was 10.7 years. Overall incidence was 0.036 per 100,000 individuals between the years of 2000 and 2013. The nasal cavity was the most frequent primary site (37.1%) and rhabdomyosarcoma was the most frequent malignancy (50.5%). Five-, 10-, and 20-year disease-specific survival (DSS) rates were 60.2%, 46.1%, and 20.6%, respectively. Grade IV tumors made up the largest group (37.3%), and such tumors exhibited the worst 5-, 10-, and 20-year survival (P < 0.05). Distant disease predicted the worst 5-, 10-, and 20-year survival, followed by regional, then localized disease (P < 0.01). Patients treated with surgery alone had a higher 20-year survival (P = 0.0425). No significant differences in survival were observed between race, gender, primary site, or histology. Conclusions PedsSNM frequently presented as Grade IV tumors. The nasal cavity was the most common primary site and rhabdomyosarcoma was the most frequent histology. Patients receiving surgery alone had the highest survival; however, this may be a reflection of smaller, less aggressive tumors preferentially being treated with surgery alone.

KW - Pediatric carcinoma

KW - Pediatric malignancies

KW - Rhabdomyosarcoma

KW - Sinonasal carcinoma

KW - Sinonasal malignancies

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=85018761836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018761836&partnerID=8YFLogxK

U2 - 10.1016/j.ijporl.2017.04.032

DO - 10.1016/j.ijporl.2017.04.032

M3 - Article

C2 - 28583514

AN - SCOPUS:85018761836

VL - 98

SP - 97

EP - 102

JO - International Journal of Pediatric Otorhinolaryngology

JF - International Journal of Pediatric Otorhinolaryngology

SN - 0165-5876

ER -